NRI

JUBILANT PHARMOVA SHARE PRICE

Sector Pharmaceuticals
BSE 530019
NSE JUBLPHARMA
828.10
-52.70 (-5.98 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

823.85

Day High

888.35

52 Week Low

607.55

52 Week High

1,309.90

All Time Low

57.36

All Time High

1,309.90

Open

865.00

Close

880.80

Volume

225,995

Mkt cap (Cr)

13,190.06

P/E ratio

41.64

P/B ratio

0.42%

Div yield

0.57%

6M return

-27.28%

1Y return

26.79%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

828.10 -5.98%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Jubilant Pharmova Ltd

Stock PE (TTM)

41.64

Promoter Holding

50.68%

Book Value

372.9209

ROCE

6.37%

ROE

0.76%

Jubilant Pharma Limited is engaged in the Pharmaceutical sector. The company has its market capitalization worth INR 11,533.55 crore as of 16th April 2021. The company was incorporated in 1978. The company has reported quarterly revenue of INR 828.94 crore at the end of December 2020. This company is listed on the Bombay Stock Exchange (BSE), having the code 530019 and on the National Stock Exchange (NSE) with the symbol JUBLPHARMA. The company is headquartered in Noida. It is a pharmaceutical company that offers products and services across the pharma value chain that includes manufacturing and supply of Allergy Therapy Products, Active Pharmaceutical Ingredients. Jubilant Pharmova Limited is a manufacturer and supplier of active pharmaceutical ingredients, radiopharmaceuticals, solid dosage formulations, advanced intermediates, allergy therapy products and nutritional products. It focuses on catering to unmet medical needs at a very affordable price. Pharmaceuticals, contract R&D providers, and patented new products are the company's three market divisions. Via a network of 49 radio pharmacies in the United States, the organisation produces and distributes radiopharmaceuticals. In Bengaluru and Noida, India, it has established two world-class research centres. Shyam S Bhartia, the company's director, oversees procedures. The company reported record profitability with annual revenue of INR 91544 million during the year, which is up by 0.5% year-on-year. In the same year, the company demerged its LSI (Life Science Ingredients) to create unique entities focused on Pharmaceuticals and LSI businesses. Jubilant Pharmova recorded a splurge of 52% year-on-year growth in quarter three. The CDMO and generics business of the company drove the increase in financials. In 2021, Fitch ratings upgraded Jubilant Pharmova Limited from BB- to BB. The up-gradation is a clear reflection of the improvements in the business profile. As of April 2021, the company announced the completion of safety and absorption studies in healthy human volunteers using a novel oral formulation of Remdesivir. The company entered into a non-exclusive licence agreement with Gilead Sciences Inc., which granted the rights to manufacture register and sell Gilead's Remdesivir in India and 126 other countries. The launch of this oral formulation of Covid medicine is likely to affect the company's growth positively.

Jubilant Pharmova share price as on 09 Apr 2025 is Rs. 828.1. Over the past 6 months, the Jubilant Pharmova share price has decreased by 27.28% and in the last one year, it has increased by 26.79%. The 52-week low for Jubilant Pharmova share price was Rs. 607.55 and 52-week high was Rs. 1309.9.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

530019

JUBLPHARMA

INE700A01033

Aug

Jubilant Pharmova Ltd FAQs

You can buy Jubilant Pharmova Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jubilant Pharmova Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 09, 2025 03:58 PM the closing price of Jubilant Pharmova Ltd was Rs.828.10.

The latest PE ratio of Jubilant Pharmova Ltd as of Apr 09, 2025 03:58 PM is 41.64

The latest PB ratio of Jubilant Pharmova Ltd as of Apr 09, 2025 03:58 PM is 0.42

The 52-week high of Jubilant Pharmova Ltd share price is Rs. 1,309.90 while the 52-week low is Rs. 607.55

According to analyst recommendations, Jubilant Pharmova Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Apr 09, 2025 03:58 PM, the market cap of Jubilant Pharmova Ltd stood at Rs. 13,190.06 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.